BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
Keyword: Certolizumab
1
Tumor necrosis factor-α inhibitor therapy and fetal risk: A systematic literature review
9/16/2014 11:44:00 AM | Browse: 1110 | Download: 777
Write to the Help Desk
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345